type 2 diabetes mellitus
Conditions
Interventions
Administration of dulaglutide 0.75mg once a week for 24 weeks.
Administration of empagliflozin 10mg per day for 24 weeks.
Sponsors
Social medical corporations Aijinkai Chibune hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Type 2 diabetic outpatients in Chibune Hospital with HbA1c over 7.0% under 75 years old. However,65 years old ond over,we select those with category 1 and HbA1c over 7.5%,and set treatment limits of HbA1c 6.5%. Patients with informed concent to perticipate this study,who have never taken SGLT2i,DPP4i,GLP1RA.
Exclusion criteria
Exclusion criteria: Patients with 75 years old and over,category 2,3. Patients who have not taken medicine for 3 months and over. Patients with impaired liver or kidney functions,who need adjustment of medicine.Patients with collagen disease or cancer.Patients who have economic reasons,and judged not to be appropriate by doctors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c(%) For patients of 65 years old and over,we follow HbA1c with causion to lower limit. | — |
Secondary
| Measure | Time frame |
|---|---|
| We assess body weight,accomplishment rates of HbA1c under 7%,blood pressure,renal function,and body fat. | — |
Countries
Japan
Contacts
Public ContactHiroyuki Sato
Social medical corporations Aijinkai Chibune hospital Department of Endocrinology and diabetes
Outcome results
None listed